This proposed sequence of events aligns well with emergent evidence indicating that administration of CGRP and PACAP, both potent vasodilators of meningeal arteries, [22, 31] can induce migraine-like headache in persons with PPTH [11, 13]. The gene discussed is ADCYAP1; the disease is migraine disorder.